Migdal Insurance & Financial Holdings’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,220
Closed -$643K 683
2021
Q1
$643K Buy
4,220
+2,619
+164% +$426K 0.01% 294
2020
Q4
$268K Buy
+1,601
New +$285K ﹤0.01% 283

Other funds holding TECX

Migdal Insurance & Financial Holdings's TECX Position: Q2 2021 in Review

Migdal Insurance & Financial Holdings sold out of Tectonic Therapeutic (TECX) in Q2 2021, closing a stake of 4,220 shares — an estimated $643K sold.

Migdal Insurance & Financial Holdings first reported a position in TECX in Q4 2020 and held it in 2 quarters. The position peaked at $643K in Q1 2021. 97 funds tracked by Wall St. Rank hold TECX as of Q2 2021.

  • Migdal Insurance & Financial Holdings reported no remaining Tectonic Therapeutic position as of Q2 2021 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 4,220 Tectonic Therapeutic shares in Q2 2021, an estimated $643K.
  • Migdal Insurance & Financial Holdings first reported a position in Tectonic Therapeutic in Q4 2020 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's Tectonic Therapeutic position peaked at $643K in Q1 2021.
  • 97 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2021.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.